Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K(ATP)) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. METHODS: We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. RESULTS: Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K(ATP) channels was greatly reduced. CONCLUSIONS: Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“can be treated with high-dose sulfonylureas despite being insulin dependent also provide a compelling case for genetic evaluation of monogenic diabetes with therapeutic and prognostic implications ( 2 – 6 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings that neonatal diabetes is most commonly due to activating mutations in genes encoding the ATP-sensitive potassium channel subunits Kir6.2 or SUR1”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
Cross sectional stature and weight reference curves for the UK, 1990.
Freeman, J. V., Cole, T. J., Chinn, S., Jones, P. R., White, E. M., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.17 · Cited by 1,457
Stoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng0197-106 · Cited by 1,106
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State
Kuo, A., Gulbis, J. M., Antcliff, J. F., Rahman, T., Lowe, E. D., Zimmer, J., Cuthbertson, J., Ashcroft, F. M., Ezaki, T., & Doyle, D. A. (2003) · Science · doi:10.1126/science.1085028 · Cited by 785
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Self-citationAssociation and Stoichiometry of KATP Channel Subunits
Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., & Bryan, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80321-9 · Cited by 692
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationMutations in the glucokinase gene of the fetus result in reduced birth weight
Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., & Ellard, S. (1998) · Nature Genetics · doi:10.1038/953 · Cited by 594
Self-citation
Cited by
Items 601–700 of 1,000
Zhang, H., Zhong, X., Huang, Z., Huang, C. F., Liu, T., & Qiu, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.22548 · Cited by 16
“2 and sulfonylurea receptor 1 (SUR1) subunits of the pancreatic ATP sensitive KATP channel, coded for by the genes KCNJ11 and ABCC8, have been identified major causes of NDM [7, 8].”
BackgroundA novel high-affinity inhibitor against the human ATP-sensitive Kir6.2 channel
Ramu, Y., Xu, Y., & Lü, Z. (2018) · The Journal of General Physiology · doi:10.1085/jgp.201812017 · Cited by 16
“PNDM has been treated with insulin therapy until about a decade ago when it was discovered to be a monogenic disorder, where gain-of-function mutations of ATP-sensitive K+ (KATP) channels in pancreatic β cells are the most common cause (Gloyn et al., 2004).”
BackgroundWolcott-Rallison syndrome in Iran: a common cause of neonatal diabetes
Asl, S. N., Vakili, R., Vakili, S., Soheilipour, F., Hashemipour, M., Ghahremani, S., Franco, E. D., & Yaghootkar, H. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0434 · Cited by 15
The application of precision medicine in monogenic diabetes
Barbetti, F., Rapini, N., Schiaffini, R., Bizzarri, C., & Cianfarani, S. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2035216 · Cited by 15
Decomposition of Slide Helix Contributions to ATP-dependent Inhibition of Kir6.2 Channels
Li, J. B. W., Huang, X., Zhang, R. S., Kim, R. Y., Yang, R. Y., & Kurata, H. T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.485789 · Cited by 15
“Mutations that perturb ATP sensitivity have been identified at numerous slide helix positions in patients with neonatal diabetes (10).”
BackgroundInfluentialWagner, V. M., Kremke, B., Hiort, O., Flanagan, S. E., & Pearson, E. R. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-008-0757-3 · Cited by 15
“This pharmacogenetic response allows patients to transfer from insulin to oral SU [ 5 , 9, 10].”
BackgroundSelf-citationEsquiaveto‐Aun, A. M., de Mello, M. P., Paulino, M. F. V. M., Minicucci, W. J., Guerra‐Júnior, G., & de Lemos‐Marini, S. H. V. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0101-9 · Cited by 15
Treatable Genetic Metabolic Epilepsies
Assi, L., Saklawi, Y., Karam, P. E., & Obeid, M. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0467-0 · Cited by 16
Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement
McDonald, T. J., Besser, R. E. J., Perry, M. H., Babiker, T., Knight, B., Shepherd, M. H., Ellard, S., Flanagan, S. E., & Hattersley, A. T. (2017) · Diabetologia · doi:10.1007/s00125-017-4383-3 · Cited by 17
Self-citationFerguson, L. R. (2008) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2008.0044 · Cited by 16
“Substantial mutations in any of the four are causal for monogenic forms of T2DM, while two of them provide targets for therapy (Barroso et al., 1999; Gloyn et al., 2004; Inoue et al., 1998; Nishigori et al., 1998).”
Šumnı́k, Z., Koloušková, S., Wales, J. K., Komárek, V., & Cinek, O. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02228.x · Cited by 15
Self-citationMichels, A. W., Jeffrey, J., & Eisenbarth, G. S. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_15 · Cited by 15
Phenotypic variability in two siblings with monogenic diabetes due to the same ABCC8 gene mutation
Cattoni, A., Jackson, C., Bain, M. D., Houghton, J., & Wei, C. H. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12826 · Cited by 15
“gene or the adenosine triphosphate (ATP)-dependent potassium channel of pancreatic β-cell.(8,9) The ATP-dependent K channel expressed on the β-cell membrane plays a critical role in insulin secretion.”
BackgroundInherited β-Cell Dysfunction in Lean Individuals With Type 2 Diabetes
Mathews, A. E. W., & Mathews, C. E. (2012) · Diabetes · doi:10.2337/db12-0373 · Cited by 14
“Inheritance of b-cell failure is clear in patients diagnosed with the MODY (maturity-onset diabetes of the young, also referred to as monogenic diabetes in youth) syndromes (1), as well as in permanent neonatal diabetes mellitus (2) where mutations in genes essential for insulin secretion associate with elevated blood…”
BackgroundNovel loss-of-function variants expand ABCC9-related intellectual disability and myopathy syndrome
Efthymiou, S., Scala, M., Nagaraj, V., Ochenkowska, K., Komdeur, F. L., Liang, R. A., Abdel‐Hamid, M. S., Sultan, T., Barøy, T., Ghelue, M. V., et al. (2024) · Brain · doi:10.1093/brain/awae010 · Cited by 14
Channeling dysglycemia: ion-channel variations perturbing glucose homeostasis
Denton, J. S., & Jacobson, D. A. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.09.004 · Cited by 16
“KATP channels carrying these mutations exhibit a gain-of-function (GOF) due to a loss of regulatory inhibition by ATP [10, 21].”
BackgroundInfluentialWebster, N. J., Searle, G. J., Lam, P. P. L., Huang, Y., Riedel, M. J., Harb, G., Gaisano, H. Y., Holt, A., & Light, P. E. (2008) · Endocrinology · doi:10.1210/en.2007-1138 · Cited by 17
“2 known to increase channel activity with a neonatal diabetic phenotype (21) as well as an association with T2D (36–40) and decreased insulin secretion (37, 40).”
BackgroundDellaManna, T., Dias-da-Silva, M. R., Chacra, A. R., Kunii, I. S., Rolim, A. L., Furuzawa, G. K., Maciel, R. M. B., & Reis, A. F. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000800005 · Cited by 16
Expression and function of ATP-dependent potassium channels in zebrafish islet β-cells
Emfinger, C. H., Welscher, A., Yan, Z., Wang, Y., Conway, H., Moss, J. B., Moss, L. G., Remedi, M. S., & Nichols, C. G. (2017) · Royal Society Open Science · doi:10.1098/rsos.160808 · Cited by 16
“Loss-of-function mutations result in congenital hyperinsulinism [3], whereas gain-of-function (GOF) mutations cause neonatal diabetes mellitus (NDM) [4,5], and polymorphisms are associated with the development of type 2 diabetes [6].”
BackgroundIklé, J. M., & Gloyn, A. L. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0067 · Cited by 15
Self-citationFlechtner, I., Vaxillaire, M., Cavé, H., Scharfmann, R., Froguel, P., & Polak, M. (2007) · KARGER eBooks · doi:10.1159/000109636 · Cited by 15
Chan, Y.-M., & Laffel, L. M. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00231.x · Cited by 14
Recent advances in the genetics of diabetes
Pearson, E. R. (2008) · Primary care diabetes · doi:10.1016/j.pcd.2007.12.005 · Cited by 14
“2 or SUR1 mutations, the KATP channel is insensitive to changes in intracellular ATP, so whatever the prevailing glucose the beta-cell will not produce insulin [9].”
BackgroundMethodSelf-citationKlupa, T., Kozek, E., Nowak, N., Cyganek, K., Gach, A., Milewicz, T., Czajkowski, K., Tołłoczko, J., Mlynarski, W. M., & Malecki, M. T. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0096 · Cited by 14
Neonatal diabetes mellitus due to L233F mutation in the KCNJ11 gene
Joshi, R., & Phatarpekar, A. (2011) · World Journal of Pediatrics · doi:10.1007/s12519-011-0254-z · Cited by 14
Resting beta-cells – A functional reserve?
Hara, M., Fowler, J. L., Bell, G. I., & Philipson, L. H. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.01.001 · Cited by 15
Griscelli, F., Feraud, O., Ernault, T., Oudrihri, N., Turhan, A. G., Bonnefond, A., Froguel, P., & Griscelli, A. B. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.07.023 · Cited by 15
Gupta, M. K., & Vadde, R. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1733666 · Cited by 14
Sperling, M. A., Tamborlane, W. V., Battelino, T., WEINZIMER, S. A., & Phillip, M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00028-7 · Cited by 16
Winkler, M., Lutz, R., Ruß, U., Quast, U., & Bryan, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805435200 · Cited by 17
Differential roles for SUR subunits in KATP channel membrane targeting and regulation
Hund, T. J., & Mohler, P. J. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01088.2010 · Cited by 15
Insights on pathogenesis of type 2 diabetes from MODY genetics
Weedon, M. N., & Frayling, T. M. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0022-6 · Cited by 13
Self-citationWalczewska-Szewc, K., & Nowak, W. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c02720 · Cited by 14
Bartolomé, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010501 · Cited by 16
Yan, Z., Fortunato, M., Shyr, Z. A., Clark, A. L., Fuess, M., Nichols, C. G., & Remedi, M. S. (2022) · Diabetes · doi:10.2337/db21-0992 · Cited by 16
“Accordingly, KATP gain-of-function (GOF) mutations cause human neonatal diabetes (2,3), and KATP-GOF polymorphisms are associated with development of type-2 diabetes (4).”
BackgroundPrinciples of Pharmacogenomics
Lam, Y. W. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812626-4.00001-2 · Cited by 25
Heo, J., Kim, S., & Cho, E.-H. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.01.016 · Cited by 13
“It is permanent and requires lifelong insulin treatment [1].”
BackgroundBabenko, A. P., & Vaxillaire, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.10.020 · Cited by 13
Taneera, J., Storm, P., & Groop, L. (2014) · Journal of Diabetes Research · doi:10.1155/2014/237535 · Cited by 14
“A Glu23Lys polymorphism (E23K) has been associated with T2D and a modest impairment in insulin secretion [21].”
Cordiner, R. L. M., & Pearson, E. R. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13596 · Cited by 14
Self-citationTransient Neonatal Diabetes: An Etiologic Clue for the Adult Diabetologist
Novak, A., Bowman, P., Kraljević, I., Tripolski, M., Houghton, J., Franco, E. D., Shepherd, M. H., Škrabić, V., & Patel, K. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.05.002 · Cited by 16
“wner of the name Diabetes Canad response to metabolically generated ATP or falling Mg-ADP; this leads to hyperpolarized beta cells, which are unable to secrete insulin as blood glucose rises (6,7).”
BackgroundKhan, V., Verma, A. K., Bhatt, D., Khan, S., Hasan, R., Goyal, Y., Ramachandran, S., Alsahli, M. A., Rahmani, A. H., Almatroudi, A., et al. (2020) · International Journal of Endocrinology · doi:10.1155/2020/5924756 · Cited by 13
SGLT2 : A Potential Target for the Pharmacogenetics of Type 2 Diabetes?
Tönjes, A., & Kovacs, P. L. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.61 · Cited by 13
Glucokinase (GCK) and other susceptibility genes for β-cell dysfunction: the candidate approach
Gloyn, A. L., Tribble, N. D., van de Bunt, M., Barrett, A., & Johnson, P. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360306 · Cited by 18
Self-citationMetabolic and degenerative disorders
Granata, T. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52899-5.00045-9 · Cited by 13
Jagadeb, M., Konkimalla, V. B., Rath, S. N., & Das, R. P. (2014) · Genomics & Informatics · doi:10.5808/gi.2014.12.4.283 · Cited by 12
“2 [8, 10, 11] have been identified as probable causes of type 1 diabetes.”
BackgroundSvalastoga, P., Kaci, A., Molnes, J., Solheim, M. H., Johansson, B. B., Krogvold, L., Skrivarhaug, T., Valen, E., Johansson, S., Molven, A., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-06012-4 · Cited by 14
“In diagnosed individuals, sulfonylurea, acting on K ATP channels in pancreatic beta cells, and thereby increasing insulin secretion specifically, improves metabolic control and quality of life [18–22].”
BackgroundSelf-citationGenetics and neonatal diabetes: towards precision medicine
Groop, L. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61428-3 · Cited by 12
Treating young adults with type 2 diabetes or monogenic diabetes
Owen, K. R. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.05.002 · Cited by 12
Bourgeois, F. L., Beltrand, J., Baz, B., Julla, J., Riveline, J., Simon, A., Flechtner, I., Djoudi, M. A., Fauret‐Amsellem, A., Vial, Y., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0324 · Cited by 12
Lin, Y., Akrouh, A., Hsu, Y., Hughes, N., Nichols, C. G., & León, D. D. D. (2012) · Channels · doi:10.4161/chan.19980 · Cited by 12
“Sulfonylureas, which specifically inhibit the K ATP channel by interacting with SUR subunits, can restore insulin secretion in these patients.(5-8) Such mutations in K ATP channels account for approximately 50% of all cases of permanent neonatal diabetes and while mutations in KCNJ11, encoding Kir6.”
BackgroundStopping insulin injections following genetic testing in diabetes: impact on identity
Shepherd, M. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03022.x · Cited by 12
Bowman, P., McDonald, T. J., Knight, B., Flanagan, S. E., Leveridge, M., Spaull, S. R., Shields, B. M., Hammersley, S., Shepherd, M. H., Andrews, R. C., et al. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000721 · Cited by 12
Self-citationInsulin gene mutations linked to permanent neonatal diabetes mellitus in Indian population
Gopi, S., Gowri, P. M., Panda, J. K., Sathyanarayana, S. O., Gupta, S., Chandru, S., Radhakrishnan, C., Raghupathy, P., Dayal, D., Mohan, V., et al. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108022 · Cited by 12
Ahn, S. Y., Kim, G.-H., & Yoo, H. (2015) · Korean Journal of Pediatrics · doi:10.3345/kjp.2015.58.8.309 · Cited by 12
Xenopus as a model system for studying pancreatic development and diabetes
Kofent, J., & Spagnoli, F. M. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.01.005 · Cited by 14
Diabetes induced by gain-of-function mutations in the Kir6.1 subunit of the KATP channel
Remedi, M. S., Friedman, J. B., & Nichols, C. G. (2016) · The Journal of General Physiology · doi:10.1085/jgp.201611653 · Cited by 12
Rabbone, I., Bobbio, A., Berger, K., Trada, M., Sacchetti, C., & Cerutti, F. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03346331 · Cited by 13
Integrative cross tissue analysis of gene expression identifies novel type 2 diabetes genesPreprint
Torres, J., Barbeira, A., Bonazzola, R., Morris, A. P., Shah, K. P., Wheeler, H. E., Bell, G. I., Cox, N. J., & Im, H. K. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/108134 · Cited by 14
Tissue-Specific Alteration of Metabolic Pathways Influences Glycemic RegulationPreprint
Ng, N. H. J., Willems, S. M., Fernandez, J., Fine, R. S., Wheeler, E., Wessel, J., Kitajima, H., Marenne, G., Rundle, J. K., Sim, X., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/790618 · Cited by 12
Multiplexed CRISPR gene editing in primary human islet cells with Cas9 ribonucleoprotein
Bevacqua, R. J., Zhao, W., Merheb, E., Kim, S. H., Marson, A., Gloyn, A. L., & Kim, S. K. (2023) · iScience · doi:10.1016/j.isci.2023.108693 · Cited by 15
Self-citationA family of orthologous proteins from centipede venoms inhibit the hKir6.2 channel
Ramu, Y., & Lü, Z. (2019) · Scientific Reports · doi:10.1038/s41598-019-50688-x · Cited by 11
Majcher, S., Ustianowski, P., Malinowski, D., Czerewaty, M., Tarnowski, M., Safranow, K., Dziedziejko, V., & Pawlik, A. (2022) · Genes · doi:10.3390/genes13081315 · Cited by 11
Sperling, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00018-4 · Cited by 12
Bowman, P., Sulen, Å., Barbetti, F., Beltrand, J., Svalastoga, P., Ethel Codner, D., Tessmann, E. H., Pb, J., Skrivarhaug, T., Pearson, E. R., et al. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.2.8 · Cited by 11
Self-citationCognitive deficits and impaired hippocampal long-term potentiation in K ATP -induced DEND syndrome
Yahil, S., Wozniak, D. F., Yan, Z., Mennerick, S. J., & Remedi, M. S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109721118 · Cited by 13
“0285], and accelerating rotarod [F(1, 24) = 6.”
BackgroundInfluentialShimajiri, Y., Yamana, A., Morita, S., Furuta, H., Furuta, M., & Sanke, T. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12070 · Cited by 11
Lang, V., Youssef, N., & Light, P. E. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0233-8 · Cited by 12
Gloyn, A. L., Mackay, D., Weedon, M. N., McCarthy, M. I., Walker, M., Hitman, G. A., Knight, B., Owen, K. R., Hattersley, A. T., & Frayling, T. M. (2006) · Diabetes · doi:10.2337/db06-0216 · Cited by 11
“2 subunit of the ATP-sensitive K channel, are a common cause of permanent neonatal diabetes (2), while the common variant in this gene (E23K), with an allele frequency of 0.”
BackgroundSelf-citationJesic, M. M., Ješić, M. D., Maglajlić, S., Sajić, S., & Necić, S. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.09.027 · Cited by 11
Souček, P., Hlaváč, V., Elsnerová, K., Václavíková, R., Koževnikovová, R., & Rauš, K. (2015) · Physiological Research · doi:10.33549/physiolres.933212 · Cited by 14
“…to the most often analyzed genes in both neonatal and maturity-onset of the young (MODY) forms of diabetes mellitus and previous studies suggested its potential use as pharmacogenetic marker for decision between therapy by oral sulfonylureas or insulin (Gloyn et al. 2004, Pearson et al. 2006).”
BackgroundGenetic Determination of Serum Levels of Diabetes-Associated Adipokines
Schleinitz, D. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.277 · Cited by 17
Pancreas and gallbladder agenesis in a newborn with semilobar holoprosencephaly, a case report
Hilbrands, R., Keymolen, K., Michotte, A., Marichal, M., Cools, F., Goossens, A., Veld, P. I. '., Schepper, J. D., Hattersley, A. T., & Heimberg, H. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0419-2 · Cited by 12
“It is monogenic in origin and mutations in the KCNJ11 gene are the most frequent cause, resulting in normal pancreas and beta cell development but impaired insulin secretion [1].”
BackgroundSelf-citationProtein complexes as psychiatric and neurological drug targets
Kato, A., & Witkin, J. M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.018 · Cited by 13
Pharmacogenetics and target identification in diabetes
Pearson, E. R. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.02.005 · Cited by 12
Self-citationViji, D., Aswathi, P., Charmine, P. P., Husain, R. S. A., Ameen, S. N., Ahmed, S. S. S. J., & Veerabathiran, R. (2018) · Gene Reports · doi:10.1016/j.genrep.2018.10.015 · Cited by 11
Diagnostic Criteria and Classification of Diabetes
Leu, J. P., & Zonszein, J. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_7 · Cited by 20
Neonatal diabetes mellitus due to pancreas agenesis: a new case report and review of the literature
Barbarini, D. S., Haslinger, V., Schmidt, K., Patch, A., Müller, G., & Simma, B. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00523.x · Cited by 11
“3 months of life (2, 3), lasting more than 2 wk and”
BackgroundPrinciples of Pharmacogenomics
Lam, Y. W. F., & Cavallari, L. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-391918-2.00001-9 · Cited by 14
Non-invasive quantification of stem cell-derived islet graft size and composition
Lithovius, V., Lahdenpohja, S., Ibrahim, H., Saarimäki‐Vire, J., Uusitalo, L., Montaser, H., Mikkola, K., Yim, C., Keller, T., Rajander, J., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06194-5 · Cited by 13
Scala, R., Li, Y., Gao, J. H., York, N., Ranjit Unnikrishnan, I., Anjana, R. M., Mohan, V., Gopi, S., Kavitha, B., Radha, V., et al. (2025) · Diabetes · doi:10.2337/db25-0110 · Cited by 11
Molecular mechanisms of centipede toxin SsTx-4 inhibition of inwardly rectifying potassium channels
Tang, D., Xu, J., Li, Y., Zhao, P., Kong, X., Hu, H., Liang, S., Tang, C. W., & Liu, Z. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101076 · Cited by 11
Abbasi, F., Saba, S., Ebrahim‐Habibi, A., Sayahpour, F. A., Amiri, P., Larijani, B. A., & Amoli, M. M. (2012) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256435 · Cited by 10
Permanent neonatal diabetes mellitus
Al-Matary, A., Hussain, M., Nahari, A., & Ali, J. (2012) · American Journal of Case Reports · doi:10.12659/ajcr.883242 · Cited by 10
“The diagnosis is made within the first 2 months of life [7].”
BackgroundMadani, H. A., Fawzy, N., Afif, A., Abdelghaffar, S., & Gohar, N. (2016) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2016.157 · Cited by 10
Using Personalized Medicine in the Management of Diabetes Mellitus
Elk, N., & Iwuchukwu, O. F. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1976 · Cited by 12
Xu, M., Hu, H., Deng, D., Chen, M., Xu, Z., & Wang, Y. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12565 · Cited by 11
“For example, it has been indicated that six single nucleotide polymorphisms, including an activating R201H mutation on KCNJ11, contribute to permanent neonatal diabetes.(40) In addition, mutations of KCNJ11 can cause permanent hyperinsulinemic hypoglycemia of infancy.”
BackgroundAssociation of ABCC8 and KCNJ11 gene variants with type 1 diabetes in south Indians
Reddy, S., Maddhuri, S., Nallari, P., Ananthapur, V., Kalyani, S., Krishna, M., Cherkuri, N., & Patibandala, S. (2021) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-021-00149-w · Cited by 10
McCarthy, M. I. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543555.024 · Cited by 11
Identifying subtypes of monogenic diabetes
Juszczak, A., & Owen, K. R. (2013) · Diabetes Management · doi:10.2217/dmt.13.59 · Cited by 13
KCNJ11 activating mutation in an Indian family with remitting and relapsing diabetes
Khadilkar, V. V., Khadilkar, A. V., Kapoor, R. R., Hussain, K., Hattersley, A. T., & Ellard, S. (2010) · The Indian Journal of Pediatrics · doi:10.1007/s12098-010-0062-9 · Cited by 10
Self-citationClark, R. H., Männikkö, R., Stuckey, D., Iberl, M., Clarke, K., & Ashcroft, F. M. (2012) · Diabetologia · doi:10.1007/s00125-011-2428-6 · Cited by 10
“Thus, at the RNA level this establishes the hemizygous m-V59M mouse as a plausible model for human patients with iDEND syndrome, all of who are heterozygotes [2, 3].”
BackgroundSelf-citationGenetic influences on the association between fetal growth and susceptibility to type 2 diabetes
Shields, B. M., Freathy, R. M., & Hattersley, A. T. (2010) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000127 · Cited by 10
Self-citationGenetic Defects of the β-Cell That Cause Diabetes
Stekelenburg, C., & Schwitzgebel, V. (2016) · Endocrine development · doi:10.1159/000439417 · Cited by 11
Diabète néonatal: une maladie aux multiples mécanismes
Flechtner, I., Vaxillaire, M., Cavé, H., Froguel, P., & Polak, M. (2007) · Archives de Pédiatrie · doi:10.1016/j.arcped.2007.08.010 · Cited by 10
Park, H. Y., Choi, H. J., & Hong, Y. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.8.1101 · Cited by 12
“KCNJ11 (potassium inwardly-rectifying channel, subfamily J, member 11) regulates glucosedependent insulin secretion, and its mutations have been reported to cause severe neonatal diabetes (25).”
BackgroundGenetics: how the UKPDS contributed to determining the genetic landscape of Type 2 diabetes
Gloyn, A. L., & McCarthy, M. I. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02500.x · Cited by 12
Self-citationAtomic Absorption Spectroscopy in Ion Channel Screening
Stankovich, L., Wicks, D., Despotovski, S., & Dong, L. (2004) · Assay and Drug Development Technologies · doi:10.1089/1540658042584161 · Cited by 10
Identifying Susceptibility Variants for Type 2 Diabetes
Zeggini, E., & McCarthy, M. I. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-389-9_16 · Cited by 11
SKUPIEN, J. K., Malecki, M. T., Mlynarski, W. M., Klupa, T., Wanic, K., Gach, A., Solecka, I., & Sieradzki, J. (2006) · The Review of Diabetic Studies · doi:10.1900/rds.2006.3.17 · Cited by 10
“2 subunit of the ATP-sensitive potassium channel [1].”
Background
Metadata
- Authors
- Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., Edghill, E. L., Frayling, T. M., Temple, I. K., Mackay, D., Shield, J. P. H., Sumnik, Z., van Rhijn, A., Wales, J. K. H., Clark, P., Gorman, S., Aisenberg, J., Ellard, S., Njølstad, P. R., Ashcroft, F. M., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- University of Oxford (GB)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Children's Hospital at Westmead (AU)
- University of Bergen (NO)
- National Health Service (GB)
- Salisbury District Hospital (GB)
- Sheffield Children's Hospital (GB)
- St. Luke's Hospital (GB)
- Hackensack University Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-04-29
- Volume
- 350
- Issue
- 18
- Pages
- 1838-1849
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012515461
- Cited by
- 1,137
- References
- 38
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 31 · 2023: 44 · 2022: 37 · 2021: 49 · 2020: 33 · 2019: 50 · 2018: 57 · 2017: 51 · 2016: 55 · 2015: 49 · 2014: 60 · 2013: 55 · 2012: 45
- FWCI
- 70.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- permanent neonatal diabetes, Kir6.2, KCNJ11, ATP-sensitive potassium channels, activating mutations, missense mutations, SUR1, tolbutamide, glucose-stimulated insulin secretion, developmental delay, muscle weakness, epilepsy, genetic diagnosis
- MeSH terms
- Developmental Disabilities, Diabetes Mellitus, DNA Mutational Analysis, Epilepsy, Face, Female, Heterozygote, Humans, Infant, Newborn, Islets of Langerhans, Male, Mutation, Pedigree, Sequence Analysis, DNA, Potassium Channels, Inwardly Rectifying
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.